Xtant Medical makes bone graft materials and spinal implant systems for spine surgeons and hospitals. It last closed at $0.21 on Nov 17, down 5.95% on the day.
Only 1 firm rated XTNT in the past 90 days, not enough for a consensus
Average 12-month target
$1.00
▲ 383.3% upside
Based on 1 analyst who set a price target on XTNT in the past 90 days. The average target is $1.00, with a high of $1.00 and a low of $1.00, compared with the last close of $0.21.
Low $1.00Avg $1.00High $1.00
Blue marker: last close $0.21
Highest target$1.00
Average target$1.00
Lowest target$1.00
Latest rating changes
LUCID CAPITAL MARKETSInitiated
Sep 2Buy$1
Date
Firm
Action
Rating
Price target
Sep 2
LUCID CAPITAL MARKETS
Initiated
Buy
$1
Loading…
Technical Analysis
XTNT · as of the Nov 17 close · updated after every close
Downtrend, oversold
The stock is 34% below its 20 day and 50% below its 50 day average. It is 113% below its 200 day average, so the longer trend is down. Momentum is weak (RSI 22), oversold. The nearest support is the Pivot S1 at $0.20, and the nearest resistance the Pivot at $0.21.
Short trendBearish
Long trendBearish
MomentumWeak
StretchOversold
VolatilityHigh, 13.7%/day
Key levels
$0.8452 week high+300.0%
$0.44200 day average+109.5%
$0.35100 day average+66.7%
$0.32Swing high (Oct 22)+52.4%
$0.3150 day average+47.6%
$0.2820 day average+33.3%
$0.22Pivot R1+4.8%
$0.21Pivot+0.0%
$0.21Last close
$0.20Pivot S1−4.8%
$0.1752 week low−19.0%
Indicators
RSI (14)
21.51
Oversold below 30
Oversold
MACD
-0.02
Below its signal line
Bearish
Stochastic
24.2
Middle of its range
Neutral
ADX (14)
20.9
Weak trend
Williams %R
-76.9
Oversold below −80, overbought above −20
Neutral
CCI (20)
-326.6
Oversold below −100, overbought above 100
Oversold
Rate of change
−28.6%
Change over 10 sessions
Bearish
ATR (14)
$0.03
Typical daily range, 13.7% of price
MA 10Below
MA 20Below
MA 50Below
MA 100Below
MA 200Below
Downtrend, oversold
Short trendBearish
Long trendBearish
MomentumWeak
StretchOversold
VolatilityHigh, 33.2%/day
Key levels
$0.8452 week high+300.0%
$0.44200 day average+109.5%
$0.35100 day average+66.7%
$0.32Swing high (Oct 22)+52.4%
$0.3150 day average+47.6%
$0.2820 day average+33.3%
$0.22Pivot R1+4.8%
$0.21Pivot+0.0%
$0.21Last close
$0.20Pivot S1−4.8%
$0.1752 week low−19.0%
Indicators
RSI (14)
27.87
Oversold below 30
Oversold
MACD
-0.06
Below its signal line
Bearish
Stochastic
8.2
Near the bottom of its range
Oversold
ADX (14)
22.6
Weak trend
Williams %R
-88.3
Oversold below −80, overbought above −20
Oversold
CCI (20)
-188.0
Oversold below −100, overbought above 100
Oversold
Rate of change
−40.2%
Change over 10 sessions
Bearish
ATR (14)
$0.07
Typical daily range, 33.3% of price
MA 10Below
MA 20Below
MA 50Below
MA 100Below
MA 200Below
What happened before, for XTNT
Signal name goes hereSince a recent date
9 times
+0.0%
Signal name goes hereSince a recent date
9 times
+0.0%
Signal name goes hereSince a recent date
9 times
+0.0%
What happened before
See how XTNT did after each of today's signals in the past: how often it was higher 10 sessions later, and the typical move, next to its usual record.
November seasonalityHow XTNT usually does this month. See Seasonality
Calculated from daily prices after each close. Signals describe the chart, not where the stock will go. Past patterns often fail. Not investment advice.
Seasonality
How XTNT has done in each calendar month: the average and median return, how often each month finished higher, and every year since 2010.
From SEC Form 13F filings for Sep 30, 2026. What the filings show, not a forecast: positions can be up to 45 days old and leave out short sales.
AI Auto Pilots
Paper trading
StreetAlpha runs four autonomous AI traders powered by Anthropic's Claude. Each one reads options flow, dark pool prints, insider filings, sentiment, macro signals and technicals, then makes its own trading decisions in a paper portfolio. Every decision is logged and every trade is tracked, so you can see whether XTNT is in one of them and how their past XTNT trades turned out.
Xtant Medical makes orthobiologics, which are bone graft materials, along with spinal implant fixation systems used in spinal fusion surgery. Its products include human bone allografts, synthetic bone graft substitutes, and amniotic membrane allografts for wound care. Orthopedic spine surgeons and neurosurgeons are the main users, and the company sells mostly in the United States through independent agents and distributors, with some sales in Europe, Canada, Mexico, South America, and parts of the Pacific region. The company is based in Belgrade, Montana.